In NB, TRPM7 overexpression reduces actomyosin-driven cytoskeletal tension which promotes SNAI2 expression, a neural crest specifier, and controls the malignant features of NB cells (Middelbeek et al., 2015). The gene discussed is SNAI2; the disease is neuroblastoma.